Skip to main content
Top
Published in: BMC Clinical Pathology 1/2009

Open Access 01-12-2009 | Research article

Ex-vivo changes in amino acid concentrations from blood stored at room temperature or on ice: implications for arginine and taurine measurements

Authors: Joshua S Davis, Christabelle J Darcy, Kim Piera, Yvette R McNeil, Tonia Woodberry, Nicholas M Anstey

Published in: BMC Clinical Pathology | Issue 1/2009

Login to get access

Abstract

Background

Determination of the plasma concentrations of arginine and other amino acids is important for understanding pathophysiology, immunopathology and nutritional supplementation in human disease. Delays in processing of blood samples cause a change in amino acid concentrations, but this has not been precisely quantified. We aimed to describe the concentration time profile of twenty-two amino acids in blood from healthy volunteers, stored at room temperature or on ice.

Methods

Venous blood was taken from six healthy volunteers and stored at room temperature or in an ice slurry. Plasma was separated at six time points over 24 hours and amino acid levels were determined by high-performance liquid chromatography.

Results

Median plasma arginine concentrations decreased rapidly at room temperature, with a 6% decrease at 30 minutes, 25% decrease at 2 hours and 43% decrease at 24 hours. Plasma ornithine increased exponentially over the same period. Plasma arginine was stable in blood stored on ice, with a < 10% change over 24 hours. Plasma taurine increased by 100% over 24 hours, and this change was not prevented by ice. Most other amino acids increased over time at room temperature but not on ice.

Conclusion

Plasma arginine concentrations in stored blood fall rapidly at room temperature, but remain stable on ice for at least 24 hours. Blood samples taken for the determination of plasma amino acid concentrations either should be placed immediately on ice or processed within 30 minutes of collection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Boger RH: The pharmacodynamics of L-arginine. J Nutr. 2007, 137: 1650S-1655S.PubMed Boger RH: The pharmacodynamics of L-arginine. J Nutr. 2007, 137: 1650S-1655S.PubMed
2.
go back to reference Ganz P, Vita JA: Testing endothelial vasomotor function: nitric oxide, a multipotent molecule. Circulation. 2003, 108: 2049-2053. 10.1161/01.CIR.0000089507.19675.F9.CrossRefPubMed Ganz P, Vita JA: Testing endothelial vasomotor function: nitric oxide, a multipotent molecule. Circulation. 2003, 108: 2049-2053. 10.1161/01.CIR.0000089507.19675.F9.CrossRefPubMed
3.
4.
go back to reference Luiking YC, Poeze M, Dejong CH, Ramsay G, Deutz NE: Sepsis: an arginine deficiency state?. Crit Care Med. 2004, 32: 2135-2145. 10.1097/01.CCM.0000142939.81045.A0.CrossRefPubMed Luiking YC, Poeze M, Dejong CH, Ramsay G, Deutz NE: Sepsis: an arginine deficiency state?. Crit Care Med. 2004, 32: 2135-2145. 10.1097/01.CCM.0000142939.81045.A0.CrossRefPubMed
5.
go back to reference Davis JS, Yeo TW, Thomas JH, McMillan M, Darcy CJ, McNeil YR, Cheng AC, Celermajer DS, Stephens DP, Anstey NM: Sepsis-associated microvascular dysfunction measured by peripheral arterial tonometry: an observational study. Crit Care. 2009, 13: R155-10.1186/cc8055.CrossRefPubMedPubMedCentral Davis JS, Yeo TW, Thomas JH, McMillan M, Darcy CJ, McNeil YR, Cheng AC, Celermajer DS, Stephens DP, Anstey NM: Sepsis-associated microvascular dysfunction measured by peripheral arterial tonometry: an observational study. Crit Care. 2009, 13: R155-10.1186/cc8055.CrossRefPubMedPubMedCentral
6.
go back to reference Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, McNeil YR, Darcy CJ, Granger DL, Weinberg JB, Lopansri BK, et al: Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria. J Exp Med. 2007, 204: 2693-2704. 10.1084/jem.20070819.CrossRefPubMedPubMedCentral Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, McNeil YR, Darcy CJ, Granger DL, Weinberg JB, Lopansri BK, et al: Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria. J Exp Med. 2007, 204: 2693-2704. 10.1084/jem.20070819.CrossRefPubMedPubMedCentral
7.
go back to reference Ochoa JB, Udekwu AO, Billiar TR, Curran RD, Cerra FB, Simmons RL, Peitzman AB: Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg. 1991, 214: 621-626. 10.1097/00000658-199111000-00013.CrossRefPubMedPubMedCentral Ochoa JB, Udekwu AO, Billiar TR, Curran RD, Cerra FB, Simmons RL, Peitzman AB: Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg. 1991, 214: 621-626. 10.1097/00000658-199111000-00013.CrossRefPubMedPubMedCentral
8.
go back to reference Boger RH, Bode-Boger SM: The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol. 2001, 41: 79-99. 10.1146/annurev.pharmtox.41.1.79.CrossRefPubMed Boger RH, Bode-Boger SM: The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol. 2001, 41: 79-99. 10.1146/annurev.pharmtox.41.1.79.CrossRefPubMed
9.
go back to reference Bernard A, Meier C, Lopez N, May J, Chang P, Boulanger B, Kearney P: Packed red blood cell-associated arginine depletion is mediated by arginase. J Trauma. 2007, 63: 1108-1112. 10.1097/TA.0b013e31814b2b17.CrossRefPubMed Bernard A, Meier C, Lopez N, May J, Chang P, Boulanger B, Kearney P: Packed red blood cell-associated arginine depletion is mediated by arginase. J Trauma. 2007, 63: 1108-1112. 10.1097/TA.0b013e31814b2b17.CrossRefPubMed
10.
go back to reference Mori M, Gotoh T: Arginine metabolic enzymes, nitric oxide and infection. J Nutr. 2004, 134: 2820S-2825S.PubMed Mori M, Gotoh T: Arginine metabolic enzymes, nitric oxide and infection. J Nutr. 2004, 134: 2820S-2825S.PubMed
11.
go back to reference Prins HA, Houdijk AP, Nijveldt RJ, Teerlink T, Huygens P, Thijs LG, van Leeuwen PA: Arginase release from red blood cells: possible link in transfusion induced immune suppression?. Shock. 2001, 16: 113-115. 10.1097/00024382-200116020-00005.CrossRefPubMed Prins HA, Houdijk AP, Nijveldt RJ, Teerlink T, Huygens P, Thijs LG, van Leeuwen PA: Arginase release from red blood cells: possible link in transfusion induced immune suppression?. Shock. 2001, 16: 113-115. 10.1097/00024382-200116020-00005.CrossRefPubMed
12.
go back to reference Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown C, Mellor AL: Prevention of allogeneic fetal rejection by tryptophan catabolism. Science. 1998, 281: 1191-1193. 10.1126/science.281.5380.1191.CrossRefPubMed Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown C, Mellor AL: Prevention of allogeneic fetal rejection by tryptophan catabolism. Science. 1998, 281: 1191-1193. 10.1126/science.281.5380.1191.CrossRefPubMed
14.
go back to reference Stapleton PP, Mahon TM, Nowlan P, Bloomfield FJ: Effects of in-vivo administration of taurine and HEPES on the inflammatory response in rats. J Pharm Pharmacol. 1994, 46: 745-750.CrossRefPubMed Stapleton PP, Mahon TM, Nowlan P, Bloomfield FJ: Effects of in-vivo administration of taurine and HEPES on the inflammatory response in rats. J Pharm Pharmacol. 1994, 46: 745-750.CrossRefPubMed
15.
go back to reference Muhling J, Fuchs M, Fleck C, Sablotzki A, Krull M, Dehne MG, Gonter J, Weiss S, Engel J, Hempelmann G: Effects of arginine, L-alanyl-L-glutamine or taurine on neutrophil (PMN) free amino acid profiles and immune functions in vitro. Amino Acids. 2002, 22: 39-53. 10.1007/s726-002-8200-9.CrossRefPubMed Muhling J, Fuchs M, Fleck C, Sablotzki A, Krull M, Dehne MG, Gonter J, Weiss S, Engel J, Hempelmann G: Effects of arginine, L-alanyl-L-glutamine or taurine on neutrophil (PMN) free amino acid profiles and immune functions in vitro. Amino Acids. 2002, 22: 39-53. 10.1007/s726-002-8200-9.CrossRefPubMed
16.
go back to reference Hainque B, Gerbet D, Roisin JP, Le Moel G, Troupel S, Galli A: [Course of the concentration of serum free amino acids as a function of time and the method of preservation]. Ann Biol Clin (Paris). 1985, 43: 221-226. Hainque B, Gerbet D, Roisin JP, Le Moel G, Troupel S, Galli A: [Course of the concentration of serum free amino acids as a function of time and the method of preservation]. Ann Biol Clin (Paris). 1985, 43: 221-226.
17.
go back to reference Schaefer A, Piquard F, Haberey P: Plasma amino-acids analysis: effects of delayed samples preparation and of storage. Clin Chim Acta. 1987, 164: 163-169. 10.1016/0009-8981(87)90067-2.CrossRefPubMed Schaefer A, Piquard F, Haberey P: Plasma amino-acids analysis: effects of delayed samples preparation and of storage. Clin Chim Acta. 1987, 164: 163-169. 10.1016/0009-8981(87)90067-2.CrossRefPubMed
18.
go back to reference Nuttall KL, Chen M, Komaromy-Hiller G: Delayed separation and the plasma amino acids arginine and ornithine. Ann Clin Lab Sci. 1998, 28: 354-359.PubMed Nuttall KL, Chen M, Komaromy-Hiller G: Delayed separation and the plasma amino acids arginine and ornithine. Ann Clin Lab Sci. 1998, 28: 354-359.PubMed
19.
go back to reference van Wandelen C, Cohen SA: Using quaternary high-performance liquid chromatography eluent systems for separating 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate-derivatized amino acid mixtures. J Chromatogr A. 1997, 763: 11-22. 10.1016/S0021-9673(96)00891-6.CrossRef van Wandelen C, Cohen SA: Using quaternary high-performance liquid chromatography eluent systems for separating 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate-derivatized amino acid mixtures. J Chromatogr A. 1997, 763: 11-22. 10.1016/S0021-9673(96)00891-6.CrossRef
20.
go back to reference Martens-Lobenhoffer J, Bode-Boger SM: Measurement of asymmetric dimethylarginine (ADMA) in human plasma: from liquid chromatography estimation to liquid chrmoatgoraphy-mass spectrometry quantification. Eur J Clin Pharmacol. 2006, 62: 61-68. 10.1007/s00228-005-0015-9.CrossRef Martens-Lobenhoffer J, Bode-Boger SM: Measurement of asymmetric dimethylarginine (ADMA) in human plasma: from liquid chromatography estimation to liquid chrmoatgoraphy-mass spectrometry quantification. Eur J Clin Pharmacol. 2006, 62: 61-68. 10.1007/s00228-005-0015-9.CrossRef
21.
go back to reference Sahai S, Uhlhaas S: Stability of amino acids in human plasma. Clin Chim Acta. 1985, 148: 255-259. 10.1016/0009-8981(85)90152-4.CrossRefPubMed Sahai S, Uhlhaas S: Stability of amino acids in human plasma. Clin Chim Acta. 1985, 148: 255-259. 10.1016/0009-8981(85)90152-4.CrossRefPubMed
22.
go back to reference Argaman Z, Young VR, Noviski N, Castillo-Rosas L, Lu XM, Zurakowski D, Cooper M, Davison C, Tharakan JF, Ajami A, Castillo L: Arginine and nitric oxide metabolism in critically ill septic pediatric patients. Crit Care Med. 2003, 31: 591-597. 10.1097/01.CCM.0000050291.37714.74.CrossRefPubMed Argaman Z, Young VR, Noviski N, Castillo-Rosas L, Lu XM, Zurakowski D, Cooper M, Davison C, Tharakan JF, Ajami A, Castillo L: Arginine and nitric oxide metabolism in critically ill septic pediatric patients. Crit Care Med. 2003, 31: 591-597. 10.1097/01.CCM.0000050291.37714.74.CrossRefPubMed
23.
go back to reference Bernard AC, Mistry SK, Morris SM, O'Brien WE, Tsuei BJ, Maley ME, Shirley LA, Kearney PA, Boulanger BR, Ochoa JB: Alterations in arginine metabolic enzymes in trauma. Shock. 2001, 15: 215-219. 10.1097/00024382-200115030-00009.CrossRefPubMed Bernard AC, Mistry SK, Morris SM, O'Brien WE, Tsuei BJ, Maley ME, Shirley LA, Kearney PA, Boulanger BR, Ochoa JB: Alterations in arginine metabolic enzymes in trauma. Shock. 2001, 15: 215-219. 10.1097/00024382-200115030-00009.CrossRefPubMed
24.
go back to reference Castillo L, Beaumier L, Ajami AM, Young VR: Whole body nitric oxide synthesis in healthy men determined from [15N] arginine-to-[15N]citrulline labeling. Proc Natl Acad Sci USA. 1996, 93: 11460-11465. 10.1073/pnas.93.21.11460.CrossRefPubMedPubMedCentral Castillo L, Beaumier L, Ajami AM, Young VR: Whole body nitric oxide synthesis in healthy men determined from [15N] arginine-to-[15N]citrulline labeling. Proc Natl Acad Sci USA. 1996, 93: 11460-11465. 10.1073/pnas.93.21.11460.CrossRefPubMedPubMedCentral
Metadata
Title
Ex-vivo changes in amino acid concentrations from blood stored at room temperature or on ice: implications for arginine and taurine measurements
Authors
Joshua S Davis
Christabelle J Darcy
Kim Piera
Yvette R McNeil
Tonia Woodberry
Nicholas M Anstey
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Clinical Pathology / Issue 1/2009
Electronic ISSN: 1472-6890
DOI
https://doi.org/10.1186/1472-6890-9-10

Other articles of this Issue 1/2009

BMC Clinical Pathology 1/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.